Panagora Asset Management’s Puma Biotechnology PBYI Stock Holding History

Panagora Asset Management’s Portfolio PBYI Stock Details PBYI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.76M	Buy	217,545 +22,658	+12%	+$166K	0.01%	659
2026 Q1	$1.25M	Hold	194,887	–	–	﹤0.01%	668
2025 Q4	$1.16M	Buy	194,887 +28,966	+17%	+$154K	﹤0.01%	681
2025 Q3	$881K	Buy	165,921 +89,237	+116%	+$378K	﹤0.01%	689
2025 Q2	$263K	Buy	+76,684	New	+$245K	﹤0.01%	973
2025 Q1	–	Sell	-58,849	Closed	-$179K	–	1176
2024 Q4	$179K	Sell	58,849 -43,180	-42%	-$126K	﹤0.01%	1085
2024 Q3	$260K	Sell	102,029 -791	-0.8%	-$2.39K	﹤0.01%	1079
2024 Q2	$335K	Buy	+102,820	New	+$451K	﹤0.01%	1016
2022 Q2	–	Sell	-205,138	Closed	-$591K	–	1569
2022 Q1	$591K	Buy	205,138 +7,066	+4%	+$18.3K	﹤0.01%	1149
2021 Q4	$602K	Buy	198,072 +2,258	+1%	+$9.8K	﹤0.01%	1131
2021 Q3	$1.37M	Sell	195,814 -5,913	-3%	-$44.3K	0.01%	822
2021 Q2	$1.85M	Sell	201,727 -14,008	-6%	-$142K	0.01%	733
2021 Q1	$2.1M	Sell	215,735 -5,508	-2%	-$61.5K	0.01%	721
2020 Q4	$2.27M	Sell	221,243 -72,517	-25%	-$734K	0.01%	663
2020 Q3	$2.96M	Sell	293,760 -2,303	-0.8%	-$23.5K	0.02%	518
2020 Q2	$3.09M	Buy	296,063 +146,974	+99%	+$1.52M	0.02%	533
2020 Q1	$1.26M	Buy	149,089 +90,512	+155%	+$879K	0.01%	758
2019 Q4	$513K	Buy	58,577 +2,779	+5%	+$23K	﹤0.01%	1294
2019 Q3	$601K	Hold	55,798	–	–	﹤0.01%	1222
2019 Q2	$709K	Buy	+55,798	New	+$1.28M	﹤0.01%	1303
2018 Q4	–	Sell	-4,528	Closed	-$208K	–	2503
2018 Q3	$208K	Sell	4,528 -35,782	-89%	-$1.73M	﹤0.01%	1666
2018 Q2	$2.38M	Buy	40,310 +10,166	+34%	+$589K	0.01%	809
2018 Q1	$2.05M	Buy	30,144 +2,126	+8%	+$159K	0.01%	864
2017 Q4	$2.77M	Buy	+28,018	New	+$3.14M	0.01%	745
2015 Q2	–	Sell	-842	Closed	-$199K	–	2457
2015 Q1	$199K	Buy	+842	New	+$180K	﹤0.01%	1673

Other funds holding PBYI

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Panagora Asset Management's PBYI Position: Q2 2026 in Review

Panagora Asset Management increased its Puma Biotechnology (PBYI) stake by 12% in Q2 2026, buying an estimated $166K and bringing the position to 217,545 shares worth $1.76M. The position accounts for 0.01% of the portfolio, ranked #659.

Panagora Asset Management first reported a position in PBYI in Q1 2015 and has held it in 25 quarters since. The position peaked at $3.09M in Q2 2020. 161 funds tracked by Wall St. Rank hold PBYI as of Q2 2026.

Panagora Asset Management held 217,545 shares of Puma Biotechnology worth $1.76M as of Q2 2026.
Panagora Asset Management bought 22,658 Puma Biotechnology shares in Q2 2026, an estimated $166K.
Puma Biotechnology made up 0.01% of Panagora Asset Management's portfolio in Q2 2026, its #659 holding.
Panagora Asset Management first reported a position in Puma Biotechnology in Q1 2015 and has held it in 25 quarters since.
Panagora Asset Management's Puma Biotechnology position peaked at $3.09M in Q2 2020.
161 funds tracked by Wall St. Rank held Puma Biotechnology as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.